It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
Today in Money: a survey has revealed the generation that hates their job the most; an airline has launched a £250 return to New York; and we take a closer look at weekly care home costs around the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback